A Potentially Misleading Name: <i>Staphylococcus argenteus</i> in an Urosepsis: A Case Report

<i>Staphylococcus argenteus</i>, a recently recognized species within the <i>Staphylococcus aureus complex</i>, shares numerous virulence traits with <i>S. aureus</i>. While <i>S. argenteus</i> typically lacks pigmentation and exhibits greater antibiotic susceptibility compared to <i>S. aureus</i>, it can cause severe infections, including bacteremia. Clinicians can be misled by its name and may not give it the necessary attention. It may also be misidentified as a <i>S. aureus</i> by the microbiology lab. We present the case of a 56-year-old man with a complex medical history who developed a polymicrobial urosepsis involving <i>S. argenteus</i>. It was initially misinterpreted as a contaminant in urinary samples by an external laboratory. The patient subsequently developed septic shock and was admitted to intensive care unit. The blood cultures confirmed <i>S. argenteus</i> associated with <i>E. coli</i> and <i>K. pneumoniae</i> bacteremia. He was successfully treated with high-dose intravenous floxacillin and oral ciprofloxacin. Whole-genome sequencing confirmed the isolate as <i>S. argenteus</i> (ST2250). This case underscores the diagnostic and clinical challenges posed by <i>S. argenteus</i>, particularly in regions where its prevalence is low. <i>S. argenteus</i> harbors the majority of <i>S. aureus</i> virulence genes and causes a comparable spectrum of disease. Epidemiological data indicate regional differences in its prevalence and clinical impact. Some studies report lower virulence while others suggest worse outcomes. The case illustrates the importance of accurate identification using techniques like MALDI-TOF MS and whole-genome sequencing. Clinicians and microbiologists should remain vigilant and consider <i>S. argenteus</i> as a pathogen, warranting appropriate antimicrobial therapy and clinical attention. Differentiating it from <i>S. aureus</i> might be relevant for guiding therapy, surveillance, and infection control, particularly given emerging reports of methicillin-resistant <i>S. argenteus</i> strains.

Authors

Institutions

Publication Details

Journal
Case Reports in Infectious Diseases
Published
2025-01-01
DOI
https://doi.org/10.1155/crdi/2880273
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Potentially Misleading Name: Staphylococcus argenteus in an Urosepsis: A Case Report

Nicolas Yin, Philippe Clevenbergh, Bhavna Mahadeb, Evelyne Maillart et al.
Case Reports in Infectious Diseases
Antimicrobial Resistance in Staphylococcus
article

A Potentially Misleading Name: Staphylococcus argenteus in an Urosepsis: A Case Report

Nicolas Yin, Philippe Clevenbergh, Bhavna Mahadeb, Evelyne Maillart, Mariana Dumitru, Y Hasnaoui, M T Talpos
article en

Abstract

<i>Staphylococcus argenteus</i>, a recently recognized species within the <i>Staphylococcus aureus complex</i>, shares numerous virulence traits with <i>S. aureus</i>. While <i>S. argenteus</i> typically lacks pigmentation and exhibits greater antibiotic susceptibility compared to <i>S. aureus</i>, it can cause severe infections, including bacteremia. Clinicians can be misled by its name and may not give it the necessary attention. It may also be misidentified as a <i>S. aureus</i> by the microbiology lab. We present the case of a 56-year-old man with a complex medical history who developed a polymicrobial urosepsis involving <i>S. argenteus</i>. It was initially misinterpreted as a contaminant in urinary samples by an external laboratory. The patient subsequently developed septic shock and was admitted to intensive care unit. The blood cultures confirmed <i>S. argenteus</i> associated with <i>E. coli</i> and <i>K. pneumoniae</i> bacteremia. He was successfully treated with high-dose intravenous floxacillin and oral ciprofloxacin. Whole-genome sequencing confirmed the isolate as <i>S. argenteus</i> (ST2250). This case underscores the diagnostic and clinical challenges posed by <i>S. argenteus</i>, particularly in regions where its prevalence is low. <i>S. argenteus</i> harbors the majority of <i>S. aureus</i> virulence genes and causes a comparable spectrum of disease. Epidemiological data indicate regional differences in its prevalence and clinical impact. Some studies report lower virulence while others suggest worse outcomes. The case illustrates the importance of accurate identification using techniques like MALDI-TOF MS and whole-genome sequencing. Clinicians and microbiologists should remain vigilant and consider <i>S. argenteus</i> as a pathogen, warranting appropriate antimicrobial therapy and clinical attention. Differentiating it from <i>S. aureus</i> might be relevant for guiding therapy, surveillance, and infection control, particularly given emerging reports of methicillin-resistant <i>S. argenteus</i> strains.

Case Reports in Infectious DiseasesVol. 2025(1)
Centre Hospitalier Universitaire Brugmann (BE), Boston University Brussels (BE)
Openalex Percentile: Top 61%
Antimicrobial Resistance in Staphylococcus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.